Omaha Public Power District, NE 2011B And 2011C Revenue Bonds Rated 'AA'; Other Ratings Affirmed Nov 11

  • ID: 2023735
  • November 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Nov. 7, 2011--Standard & Poor's Ratings Services has assigned its 'AA' rating to Omaha Public Power District (OPPD), Neb.'s electric system revenue bonds series 2011B and C. At the same time, Standard & Poor's its 'AA' rating on the district's parity senior-lien obligations. Standard & Poor's also affirmed its 'AA-' rating on OPPD's subordinate-lien bonds and periodically issued bonds, and its 'A-1+' commercial paper rating, all of which are subordinate to the 2011B and C bonds. The outlook on the long-term ratings is stable. "In our view, factors supporting the ratings include a diversified customer base, historically reliable and low cost power supply, unregulated rate-setting ability, strong financial ratios, and a moderate debt burden," said...

Companies mentioned in this report are:
- Omaha Pub Pwr Dist

Action: Affirmed
Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Omaha Pub Pwr Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.